Lead Dry AMD Program
Dry Age-Related Macular Degeneration
PreclinicalActive
Key Facts
Indication
Dry Age-Related Macular Degeneration
Phase
Preclinical
Status
Active
Company
About Perceive Biotherapeutics
Perceive Biotherapeutics is a private, preclinical-stage biotech founded in 2021 and based in Cambridge, Massachusetts. The company is built upon exclusive access to foundational research on two of the strongest protective biological pathways in retinal degeneration. Led by a seasoned team with extensive experience in ophthalmology and drug development, Perceive Bio is advancing a diversified pipeline aimed at halting vision loss in conditions like dry AMD. The company is currently preparing its lead programs for clinical entry.
View full company profileTherapeutic Areas
Other Dry Age-Related Macular Degeneration Drugs
| Drug | Company | Phase |
|---|---|---|
| Dry-AMD High-Throughput Model | Axol Bioscience | Research/Preclinical Tools |
| elamipretide (ophthalmic) | Stealth BioTherapeutics | Phase 3 |
| Undisclosed PolyCol program | Stuart Therapeutics | Pre-clinical |